###begin article-title 0
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB</italic>
###xml 333 337 333 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 364 368 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Alternative splicing is a widespread mechanism of gene expression regulation. Previous analyses based on conventional RT-PCR reported the presence of an unspliced c-fos transcript in several mammalian systems. Compared to the well-defined knowledge on the alternative splicing of fosB, the physiological relevance of the unspliced c-fos transcript in regulating c-fos expression remains largely unknown. This work aimed to investigate the functional significance of the alternative splicing c-fos pre-mRNA.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 237 240 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 454 458 454 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
###xml 513 518 <span type="species:ncbi:10090">mouse</span>
A set of primers was designed to demonstrate that, whereas introns 1 and 2 are regularly spliced from primary c-fos transcript, intron 3 remains unspliced in part of total transcript molecules. Here, the two species are referred to as c-fos-2 (+ intron 3) and spliced c-fos (- intron 3) transcripts. Then, we used a quantitatively rigorous approach based on real-time PCR to provide, for the first time, the actual steady-state copy numbers of the two c-fos transcripts. We tested how the mouse-organ context and mouse-gestational age, the synthesis and turnover rates of the investigated transcripts, and the serum stimulation of quiescent cells modulate their absolute-expression profiles. Intron 3 generates an in-frame premature termination codon that predicts the synthesis of a truncated c-Fos protein. This prediction was evaluated by immunoaffinity chromatography purification of c-Fos proteins.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 94 102 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 262 265 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 350 353 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 505 511 501 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-fos </italic>
###xml 698 704 694 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-fos </italic>
We demonstrate that: (i) The c-fos-2 transcript is ubiquitously synthesized either in vivo or in vitro, in amounts that are higher or similar to those of mRNAs coding for other Fos family members, like FosB, DeltaFosB, Fra-1 or Fra-2. (ii) Intron 3 confers to c-fos-2 an outstanding destabilizing effect of about 6-fold. (iii) Major determinant of c-fos-2 steady-state levels in cultured cells is its remarkably high rate of synthesis. (iv) Rapid changes in the synthesis and/or degradation rates of both c-fos transcripts in serum-stimulated cells give rise to rapid and transient changes in their relative proportions. Taken as a whole, these findings suggest a co-ordinated fine-tune of the two c-fos transcript species, supporting the notion that the alternative processing of the precursor mRNA might be physiologically relevant. Moreover, we detected a c-Fos immunoreactive species corresponding in mobility to the predicted truncated variant.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 384 387 384 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB</italic>
###xml 396 402 396 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fra-1 </italic>
###xml 406 412 406 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fra-2 </italic>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
Activator protein-1 (AP-1) is a dimeric transcription factor regulating major physiological processes such as cell proliferation, differentiation, neoplastic transformation, apoptosis, and response to stress [1]. Main AP-1 components in mammals are members of the Fos and Jun protein families. The Fos family includes the products of the c-fos (the cellular counterpart of oncogene v-fos), fosB, fra-1 and fra-2 genes. Fos proteins associate with Jun, but also with other basic leucine-zipper (bZIP) proteins to create a variety of AP-1 complexes [2].
###end p 9
###begin p 10
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 213 217 213 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
The expression of c-fos is subjected to a tight regulation at multiple levels. The c-fos gene undergoes rapid and transient transcriptional activation in response to a variety of extracellular stimuli [3]. Both c-fos mRNA and protein turn over with short half-lives [4,5]. Additionally, when the c-Fos protein is over-synthesized, the c-fos gene is transcriptionally repressed [6].
###end p 10
###begin p 11
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 584 585 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 660 665 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 1190 1191 1186 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1192 1194 1188 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
Alternative splicing is a widespread mechanism of gene expression regulation. The typical form of this regulation results from tissue- or temporal-specific splicing events that lead to the synthesis of either productive (protein-coding) or non-productive (no protein- coding) RNAs. Regarding transcription factors, alternative splicing preferentially adds or deletes domains that are important for their architectures and functions ([7] and references herein). The production of multiple isoforms is a common strategy for regulating the activity of genes within the Fos family (e.g. [8]). A particularly instructive example is the differential splicing of the fosB transcript, which generates two mRNAs that encode proteins with antagonistic activities. Briefly, alternative splicing removes codons 238-284 and causes a shift in the reading frame that places a stop codon following the bZIP region. The truncated protein (referred to as DeltaFosB), missing the C-terminal 101 aa of FosB, functions as a trans-negative regulator of transcriptional activation and transformation, presumably by competing with the full-length Fos protein in the dimerization with Jun and binding to DNA steps [9-11].
###end p 11
###begin p 12
###xml 19 21 19 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 22 24 22 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 478 482 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB</italic>
###xml 517 520 517 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 550 554 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 202 205 <span type="species:ncbi:10116">rat</span>
###xml 278 283 <span type="species:ncbi:10090">mouse</span>
###xml 352 357 <span type="species:ncbi:10090">mouse</span>
###xml 368 373 <span type="species:ncbi:10090">mouse</span>
###xml 378 383 <span type="species:ncbi:9606">human</span>
Previous analyses [12,13] based on RT of total RNA followed by conventional PCR have reported the presence of a transcript isoform (hereinafter referred to as c-fos-2) in several mammalian systems: (i) rat brain following kainic acid treatment, (ii) primary cortical culture of mouse brain treated with lipopolysaccharide, (iii) cartilage from newborn mouse, and (iv) mouse and human cultured stromal cells. Compared to the well-defined knowledge on the alternative splicing of fosB, the physiological relevance of c-fos-2 transcript in regulating c-fos expression has not been well addressed.
###end p 12
###begin p 13
###xml 123 126 123 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 489 493 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
The work described herein aimed to gain further insights into the functional significance of the alternative splicing of c-fos. To this end, we first undertook a systematic and meticulous quantitation of the real copy numbers of c-fos transcript variants by means of a real-time PCR methodology [14-17]. We tested how the organ context, gestational age, synthesis and turnover rates, and serum stimulation of quiescent cells modulate the absolute expression profiles of the investigated c-fos transcripts. The translation of these transcripts predicts the synthesis of a truncated c-Fos protein, in addition to the canonical full-length counterpart. From cultured cells we partially purified a c-Fos immunoreactive species corresponding in mobility to the predicted truncated species.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Alternative splicing variants of c-fos messenger
###end title 15
###begin p 16
###xml 147 151 147 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 741 745 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 892 896 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 908 910 908 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
Differential pre-mRNA splicing is an important mode of regulating the steady-state abundance of a specific mRNA. Based on the known structure of c-fos gene (Fig. 1A), a set of primers (Fig. 1B) was designed to investigate the occurrence of any splicing variant that might be derived from the primary c-fos transcript. Gene fosB was included for comparison. Primer pairs E1U-E2L and E2U-E3L (located in exons 1 and 2 and in exons 2 and 3, respectively) generated single RT-PCR amplicons of expected sizes and sequences after regular splicing of introns 1 and 2 (Fig. 1C). However, the primer pair E3U-E4L revealed the presence of two transcript populations: while the shorter amplicon (141 nt) corresponded to the canonical spliced form of c-fos message, the larger amplicon (258 nt) retained the 117 nt of intron 3. These data confirmed that intron 3 is not always spliced from the primary c-fos transcript [12,13]. To quantitate this second transcript species, an additional primer pair (E3U-I3L) was designed. As expected, these primers gave a unique RT-PCR product of the predicted size (120 nt) and sequence.
###end p 16
###begin p 17
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RT-PCR amplicons from c-fos and fosB transcripts</bold>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB</italic>
###xml 1043 1047 1043 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1090 1091 1090 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
RT-PCR amplicons from c-fos and fosB transcripts. A) Schematic drawing of c-fos and fosB gene structures. Exons (E) are boxed and shaded in grey. Introns (I) are indicated by lines between exons, except for the alternatively spliced sequences that are indicated by brick filled in boxes. The beginning and end of exons are indicated by the corresponding nucleotide positions (NCBI/GeneBank accession numbers:  and  for c-fos and fosB, respectively). B) Names, sequences and 5'-position of upper (U) and lower (L) primers. C) Agarose (1.5%) gel electrophoresis analysis of RT-PCR products generated by different primer pairs (identified at the top of each line). Total RNA from NIH 3T3 cells was used as template. Forty cycles of PCR were performed as detailed [16]. Genomic DNA was further amplified by the E1U-E2L primer pair to exclude the possibility that our PCR conditions were not optimal for the amplification of the longest theoretical fragment, i.e. the 933 nt amplicon that should be observed if intron 1 remained unspliced in the c-fos transcript population [see Additional file 7]. The molecular weight marker was a 100-nt ladder from Roche.
###end p 17
###begin title 18
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Steady-state molecules of c-fos transcripts in animal tissues and cultured cells
###end title 18
###begin p 19
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
###xml 312 318 <span type="species:ncbi:10090">murine</span>
Here we used a quantitatively rigorous approach based on RT and real-time PCR amplification [14-17] to provide novel information on the actual steady-state copy numbers of the two c-fos transcripts. Quantitations were carried out in adult mouse organs, whole mouse embryos at different developmental stages, and murine cultured cells.
###end p 19
###begin p 20
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 191 195 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 804 805 804 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
We found that both transcripts were ubiquitously expressed and presented vast differences in abundance depending on the sample (Fig. 2). In the adult organs examined, the canonical spliced c-fos mRNA displayed high steady-state levels in brain (10 molecules/pg of total RNA) followed by heart, lung, and ovary (average of 4 molecules/pg), as compared to spleen and testis (about 0.4 molecules/pg), and the rest of the organs (around 0.07 molecules/pg). Notably, this quantitative tissue-expression profile is not in good agreement with qualitative RT-PCR results in public database. For instance, qualitative RT-PCR (accession ID, MGI:1204456) generated a strong c-fos amplification band from either liver or lung RNA and no detectable signal from kidney RNA. However, quantitative data given here (Fig. 2) showed much lower expression levels in both liver and kidney (around 0.07 molecules/pg RNA) than in lung (5.7 molecules/pg RNA). These discrepancies might be due, at least partly, to the experimental uncertainties of the end-point RT-PCR methodology.
###end p 20
###begin p 21
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Organ-, embryo-, and cell type-associated differences in basal amounts of c-fos transcripts</bold>
###xml 554 557 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 590 593 590 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 611 614 611 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
Organ-, embryo-, and cell type-associated differences in basal amounts of c-fos transcripts. Data are the numbers of transcript molecules per pg of total RNA. Regarding cultured cells, error bars (SEM) indicate transcript level variability among 13 (NIH 3T3) or 8 (Hepa1-6) independent cultures. Total RNA (pool of ~200 BALB/c mice) from animal organs and whole embryos were from Clontech. No error bars are shown for quantitations of these commercial samples of total RNA. E17 embryos are in late gestation (total of about 19 days). The percentage of c-fos-2 in total transcript amount (c-fos-2 plus spliced c-fos) is indicated for each of the sample examined.
###end p 21
###begin p 22
###xml 6 9 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 299 303 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 595 600 <span type="species:ncbi:10090">mouse</span>
The c-fos-2 variant was present in smaller amounts in all 8-tissue samples, where its presence accounted for different percentages of the total transcript molecules, ranging from more than 20% in lung and ovary to about 2% in testis. Regarding whole embryos, an over 7-fold overexpression in both c-fos transcripts occurred as early as E7 (gastrulating embryos). Thereafter, their amounts declined to approximately the average numbers of the steady-state copies measured in adult tissues. Therefore, the c-fos-2 species accounted for a constant 8-9% of the total transcript molecules throughout mouse embryonic development.
###end p 22
###begin p 23
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 303 306 303 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 438 439 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 481 487 481 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos-2 </italic>
Elevated levels of the two c-fos transcripts were also quantitated in NIH 3T3 and Hepa1-6 confluent cells. Interestingly, at least in these 2 cell lines, we observed both products with an about equal yield. This finding differs from a recent report in which confluent stromal cells expressed only the c-fos-2 transcript [13]. With regard to the absolute amounts of transcripts coding for the rest of proteins within the Fos family (Table 1 and data not shown), we found that the c-fos-2 variant was nearly as abundant in lung, liver, and kidney and in NIH 3T3 cells as the transcripts coding for Fra-1 and Fra-2. Comparatively, the transcript coding for FosB displayed a much lower level.
###end p 23
###begin p 24
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
Absolute steady-state levels of transcripts encoding proteins of the Fos family in mouse lung
###end p 24
###begin p 25
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">Mice</span>
Male BALB/c mice of 7 weeks of age were obtained from Charles River Laboratories (Spain). Following a 3-day acclimation period animals were individually killed by cervical dislocation. The lung was removed and immediately frozen in liquid nitrogen. Mice were handled according to the norms stipulated by the European Community. The investigation was performed after approval by the Ethical Committee of the University of Cordoba (Spain). Data are transcript molecules/pg of total RNA.
###end p 25
###begin title 26
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Differential stability of the two c-fos transcripts
###end title 26
###begin p 27
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 499 503 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 707 711 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 752 760 752 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 888 913 888 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1214 1217 1214 1217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 1428 1432 1428 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 455 461 <span type="species:ncbi:10090">murine</span>
###xml 888 912 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 1334 1338 <span type="species:ncbi:10090">mice</span>
The intrinsic stability of any transcript is an important component of the gene expression program. We first tried to determine the half-life of each investigated c-fos transcript in a whole animal study. For this purpose, we administered actinomycin D (AmD) to stop transcription and then quantitated the number of transcript molecules remaining at various times after the transcription shut-off. Surprisingly, in contrast to previous results with other murine mRNAs [15], the decay rates of the c-fos transcripts could not be calculated in animals, since their hepatic, pulmonary and renal levels increased (not decreased) upon the intraperitoneal injection of AmD (Fig. 3). These results indicate that c-fos (an early response gene) is up-regulated in vivo by AmD under conditions in which the transcription of other genes is blocked [15]. We have previously addressed this problem in Saccharomyces cerevisiae [18], where the levels of mRNAs that are particularly responsive to environmental changes are up-regulated by current procedures for blocking transcription (i.e. RNA polymerase inhibition by specific drugs or thermal inactivation of a temperature-sensitive mutant). Since AmD doses higher than 2 mg kg-1 body weight and incubation times longer than 16 h could not be used without affecting the apparent healthy aspect of mice, we next considered the possibility of quantifying the decay rates of the investigated c-fos transcripts in the cell-cultured model.
###end p 27
###begin p 28
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Time-courses of c-fos transcripts in mouse kidney, lung and liver in response to AmD</bold>
###xml 171 174 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 737 746 733 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">post hoc </italic>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
Time-courses of c-fos transcripts in mouse kidney, lung and liver in response to AmD. Male BALB/c mice (see legend of Table 1) were intraperitoneally injected with 2 mg kg-1 body weight of AmD dissolved in phosphate-buffered saline. Animals injected with phosphate-buffered saline served as vehicle controls. Total RNA was extracted at the indicated times. Data are the means of c-fos (triangles) or c-fos-2 (circles) molecules/pg of total RNA +/- SEM (n = 3 mice). Data at 0 min represent the mean values +/- SEM of 5 control mice. No time-related effect was noted in these vehicle controls. Some error bars are not visible because of small standard errors. Statistical significance was evaluated using analysis of variance followed by post hoc multiple comparison according to the Student-Newman-Keuls method. Significant differences relative to control animals are indicated by filled-in symbols. For each transcript, the maximal fold increment is given in parentheses.
###end p 28
###begin p 29
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos-</italic>
###xml 587 591 587 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 709 712 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 787 791 787 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 853 854 853 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 874 877 874 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 884 889 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
In contrast to animals, in cultured cells the molecule number of each c-fos transcript isoform decayed exponentially in the presence of AmD and their half-lives were readily calculated from the equation of each decay line (Fig. 4A). The turnover of the two spliced forms of fosB mRNA and those of various non proto-oncogene transcripts were also determined for comparison (Fig. 4B). We found that the two species of c-fos transcripts displayed rather different half-lives in cultured cells: the c-fos-2 decayed with a half-life of less than 3 min, whereas the half-life of the spliced c-fos messenger was over 15 min (Fig. 4A). Moreover, the kinetics and magnitudes of the quantitated decays suggested that c-fos-2 is not merely a splicing intermediate in the production of the mature c-fos transcript [see theoretical considerations in Additional file 1]. In contrast to c-fos, both fosB transcripts exhibited identical half-lives of about 4 min (Fig. 4B). Transcript turnover rates in the order of minutes was a characteristic of proto-oncogenes since other mRNA species such as those encoding for heme oxygenase 1, thioredoxin 1, and superoxide dismutase 3 presented turnover rates in the order of hours.
###end p 29
###begin p 30
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rates of transcript decay and synthesis in cultured cells</bold>
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 296 299 296 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1/2</sub>
###xml 860 865 860 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 874 878 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB</italic>
###xml 906 909 902 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ho1</italic>
###xml 927 931 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trx1</italic>
###xml 961 965 957 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sod3</italic>
Rates of transcript decay and synthesis in cultured cells. A) Decay rates of the c-fos-2 (open symbols) and c-fos (solid symbols) transcripts in NIH 3T3 (circles) and Hepa1-6 (triangles) cells. Data are the percentages of transcript molecules remaining after the addition of AmD. The half-life (t1/2) values calculated from the resulting decay lines are given for comparisons. B) Rates of transcript decay and synthesis in NIH 3T3 cells. Transcript synthesis rates (in molecules/min) were calculated from the basal amounts of transcript molecules (per pg of total RNA) and their estimated half-lives (in minutes). These calculations are based on the assumption that though mRNA degradation is a complex process, it follows first-order kinetics[36]. The steady-state levels and rates of decay and synthesis of transcripts coding for both types of FosB protein (fosB and DeltafosB) and for heme oxygenase 1 (ho1), thioredoxin 1 (trx1) and superoxide dismutase 3 (sod3) are included for comparison.
###end p 30
###begin p 31
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos-</italic>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos-</italic>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 610 614 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos-</italic>
###xml 719 723 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 766 771 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
The steady-state abundance of any transcript depends on the balance between two opposing factors, its rate of formation and degradation. We show that though both c-fos transcripts are similarly abundant in cultured cells, the c-fos-2 turned over about 6-fold faster than the spliced c-fos mRNA. Both findings can only be conciliated if, at the same time, the c-fos-2 isoform is produced at a higher rate. Having determined the numbers of transcript copies and the transcript half-lives, we can estimate their synthesis rates. The result of such a calculation (Fig. 4B) suggests that the major determinant of c-fos-2 transcript level in cultured cells is its high rate of synthesis, as compared to that of the spliced c-fos variant, and particularly to those of both fosB and of non proto-oncogenes mRNAs.
###end p 31
###begin p 32
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 386 387 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 450 454 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Next, we asked ourselves whether cycloheximide (Cx), a protein synthesis inhibitor, leads to the stabilization of the alternative c-fos-2 transcript. We found (Fig. 5), that the fast decay rate of the c-fos-2 species is not coupled to translation, since it went on being </= 3 minutes in the presence of Cx, irrespective of the cell type (NIH 3T3 or Hepa1-6). In contrast, as expected [5], the inhibition of the translation transformed the spliced c-fos mRNA into a stable species (at least in the 120 min period examined).
###end p 32
###begin p 33
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Changes in transcript decay upon translation inhibition</bold>
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Changes in transcript decay upon translation inhibition. Decay rates of c-fos-2 (circles) and c-fos (triangles) transcripts were determined as in Fig. 4, excepting that half of the plates were pretreated for 15 min with Cx (10 mug/ml). Then, AmD was added to all the plates and transcript decay was followed in the presence (solid symbols) and absence (open symbols) of Cx.
###end p 33
###begin title 34
Transcript levels upon serum stimulation
###end title 34
###begin p 35
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 241 244 241 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
Previous studies have shown that the stimulation of quiescent cells with 15% CS causes a rapid transient increase in c-fos mRNA [19]. To gain more insight into the mechanisms that might be influencing the cellular level of the alternative c-fos-2 transcript, we decided to analyse whether its accumulation mode after serum induction was identical or not to that of the canonical spliced mRNA.
###end p 35
###begin p 36
###xml 15 16 15 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 318 321 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 572 576 572 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 638 642 638 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos-</italic>
###xml 914 919 914 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1005 1010 1005 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 1039 1044 1035 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 1228 1233 1220 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 1270 1271 1262 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
We found (Fig. 6) that CS induced different expression profiles for both the spliced c-fos and the c-fos-2 transcript variant. In both cases, a dramatic 11-fold increase (from about 2.3 to 25 molecules/pg) was quantitated as soon as 5 min after serum addition. However, following this early up-regulation, while the c-fos-2 copy number remained relatively constant within 5-30 min, the amount of the spliced c-fos mRNA increased until a maximum of 100-fold was reached 30 min past stimulation. Thereafter, both transcript levels decayed with different kinetics: spliced c-fos mRNA molecules decreased to 50% of maximum in 20 min, while c-fos-2 lasted 37 min. Overall, these distinguishing features caused rapid changes in the relative abundance of both transcripts throughout the period analyzed in this experiment. Comparatively, our quantitative PCR analysis revealed a much less differential expression of both fosB mRNA isoforms. Moreover, in contrast to previous observations [11], the expression of fosB did not precede that of DeltafosB mRNA at any time following serum stimulation. In fact, both transcripts were induced in a close parallelism throughout the first 30 min of serum treatment, and, additionally, the DeltafosB mRNA increase persisted longer (Fig. 6).
###end p 36
###begin p 37
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Time-course of c-fos (left) and fosB (right) transcript levels in serum-stimulated NIH 3T3 cells</bold>
Time-course of c-fos (left) and fosB (right) transcript levels in serum-stimulated NIH 3T3 cells. Data are the means of transcript molecules per pg of total RNA +/- SEM from independent cultures. Some error bars are not visible because of small SEM.
###end p 37
###begin p 38
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 405 408 405 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 564 567 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 713 717 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 842 846 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1030 1031 1030 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
Rapid changes in the rate of synthesis and/or the rate of degradation of either the canonical c-fos mRNA or the c-fos-2 variant, or both, would give rise to rapid changes in the relative magnitudes of these transcripts. We examined this possibility by calculating the formation and degradation rates of both transcripts in quiescent and serum-stimulated cells. As shown in Table 2, the half-life of the c-fos-2 variant remained essentially identical to that seen for this transcript in confluent cells. Therefore, serum-related changes in the copy number of the c-fos-2 transcript were entirely explained by differences in its rate of synthesis. Nonetheless, two trends could be envisaged regarding the spliced c-fos mRNA: while an outstanding induction of its synthesis would be the only determinant for the large up-regulation of spliced c-fos mRNA within the first 30 minutes after serum addition, the subsequent rapid return of this transcript to the prestimulation levels would require an accelerated turnover rate (see Fig. 6).
###end p 38
###begin p 39
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
Rates of synthesis and degradation of c-fos and c-fos-2 transcripts upon serum stimulation
###end p 39
###begin p 40
Experimental conditions are as in Figs. 4 and 6. Confluent cell data are those in Fig. 4.
###end p 40
###begin title 41
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
Translation of c-fos-2 transcript
###end title 41
###begin p 42
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos-</italic>
###xml 336 339 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 577 580 577 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 653 658 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 696 701 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gpx1 </italic>
Intron 3 generates in c-fos-2 transcript an in-frame translation premature termination codon (PTC), thereby predicting (if translated) the synthesis of a C-terminally truncated protein 169 aa long. In an attempt to obtain experimental proof of the synthesis of the predicted truncated c-Fos protein, we first investigated whether the c-fos-2 transcript was present in the cellular cytoplasm. To this end, RNA was isolated from separate cytoplasmic and nuclear fractions of NIH 3T3 cells, and then the resulting RNAs were analyzed by end-point RT-PCR. As shown in Fig. 7, the c-fos-2 transcript was present in both cellular fractions, like the unspliced fosB transcript. In contrast, no unspliced gpx1 pre-mRNA was present in the cytoplasmic fraction showing an efficient cellular fractionation.
###end p 42
###begin p 43
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RT-PCR analysis of cytoplasmic and nuclear RNAs</bold>
###xml 332 335 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 423 428 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 603 608 594 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink">GPX1 </sub>
###xml 652 657 643 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gpx1 </italic>
###xml 677 682 668 673 <sub xmlns:xlink="http://www.w3.org/1999/xlink">GPX1 </sub>
###xml 721 726 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gpx1 </italic>
###xml 782 786 773 777 <sub xmlns:xlink="http://www.w3.org/1999/xlink">GPX1</sub>
###xml 789 794 780 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink">GPX1 </sub>
###xml 942 947 933 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gpx1 </italic>
###xml 1094 1099 1085 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gpx1 </italic>
RT-PCR analysis of cytoplasmic and nuclear RNAs. Cytoplasmic (C) and nuclear (N) RNAs were isolated by using the PARIStrade mark Kit (Ambion) according to the manufacturer's protocol. RT-PCR conditions were as in Fig. 1. The RT-PCR product of 120 nt amplified by the E3U-I3L primer pair (see Fig. 1) indicates the presence of the c-fos-2 transcript in both cytoplasmic and nuclear fractions. Amplification of the unspliced fosB transcript (I4U-I4L primers) was included for comparison. Transcript coding for glutathione peroxidase 1 was amplified as control of efficient cellular fractionation. Primer UGPX1 (5'-GCAGAAGCGTCTGGGACCTCGTG) was located in gpx1 exon 1, and primer LGPX1 (5'-GGGAATTCAGAATCTCTTCATTCT TGCCA) in gpx1 exon 2 (the intron between both exons is 218 nt long). UGPX1- LGPX1 primers generated a single RT-PCR product of 101 nt when using the cytoplasmic RNA as template, indicating no detectable contamination with nuclear gpx1 pre-mRNA. In contrast when using the nuclear RNA as template, a fragment 319 nt long was detected in addition to the expected product from spliced gpx1 mRNA. Since the Ambion's PARIStrade mark Kit is designed for the isolation of both RNA and protein from the same sample, efficient cellular fractionation was further confirmed by Western blot analysis (botton panel) with an Ab specific for the cytoplasmic glyceraldehyde-3-phosphate-dehydrogenase (GAPDH). GAPDH was present only in the cytoplasmic fraction, further indicating no detectable contamination with the nuclear fraction.
###end p 43
###begin p 44
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 576 577 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1062 1063 1062 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1280 1281 1280 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1170 1176 <span type="species:ncbi:9986">rabbit</span>
Given the presence of the c-fos-2 transcript in the cytoplasm, we next evaluated whether the truncated c-Fos variant accumulated in serum-stimulated cells. For this purpose, c-Fos proteins were partially purified by immunoaffinity chromatography from NIH 3T3 cell extract following 30 min serum stimulation. Immunoblot analysis with anti-cFos Ab of the eluate column revealed several electrophoretically distinguishable bands (Fig. 8B). The higher molecular weight bands matched the multiple forms of the full-length c-Fos protein that appeared in the range of 53- to 68-kDa [4,20]. Bands detected in the range of 42- to 50-kDa might be c-Fos breakdown products. Finally, the discrete immunoreactive species corresponding in mobility to a ~23-kDa protein would be the truncated c-Fos form. This band was not detected in crude extract from either serum-starved or serum-stimulated cells. The possibility that the ~23-kDa band would be primary Ab light chains leaching off the immunoaffinity column was excluded by using only the secondary Ab [see Additional file 2]. Furthermore, the possibility that the ~23-kDa band would be a non-specific protein co-purified with the rabbit anti-cFos Ab was excluded by using a different primary Ab in the Western blotting [see Additional file 3].
###end p 44
###begin p 45
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Detection of c-Fos immunoreactive species</bold>
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
Detection of c-Fos immunoreactive species. A) Nucleotide sequence of c-fos intron 3 and flanking exons 3 and 4. Lower case letters refer to intronic nucleotides and upper case letters to exonic nucleotides. Minimal functional sequences within the mCRD are underlined. The encircled triplets encode the aa residues that contact to DNA. Triplets encoding two out of the five-leucine residues of the LZ motif are indicated in italics. The stop codon in intron 3 is boxed and shaded in grey. B) Western blot analysis of c-Fos proteins purified by immunoaffinity chromatography. A crude extract from NIH 3T3 cells stimulated with serum for 30 min was loaded onto the immunoaffinity column. The column eluate (E-30), as well as the input crude extract (CE-30) and the crude extract from serum-starved (CE-0) cells were subjected to inmunoblot analysis as described under "Methods". The positions of molecular size standards are indicated on the left in kDa. GAPDH was used for loading control.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 407 411 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 451 456 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
c-Fos proto-oncoprotein is a key cell regulator, whose improper expression is oncogenic, both in cultured cells and living organisms. To avoid the deleterious effects of deregulated expression, c-fos is subjected to numerous transcriptional and posttranscriptional controls [2]. Differential pre-mRNA splicing is an important mode of regulating the activity of mammalian genes (e.g. [7]). Our interest in c-fos splicing stems from previous studies on fosB where a truncated spliced variant missing the C-terminus of FosB appears to be of great physiological relevance, e.g. in mediating long-term adaptive changes in the nervous system [21].
###end p 47
###begin p 48
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 210 213 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 603 607 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 629 632 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 769 772 769 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 821 829 821 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 832 841 832 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1024 1027 1020 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1274 1278 1270 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1325 1328 1321 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1353 1356 1349 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1583 1586 1579 1582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 678 683 <span type="species:ncbi:10090">mouse</span>
###xml 1073 1078 <span type="species:ncbi:10090">mouse</span>
Murine c-fos gene comprises 4 exons and 3 introns spanning ~3.4 kb of chromosome 12. By means of specific primers, we first explored the presence of intron sequences in the transcript population derived from c-fos. We demonstrated that whereas introns 1 and 2 are regularly spliced from the precursor RNA, intron 3 remains unspliced in part of the total transcript molecules. Following this finding, we performed a robust and sensitive RT-PCR methodology for providing for the first time a comprehensive quantitation of the absolute expression levels of each transcript isoform: the canonical spliced c-fos and the alternative c-fos-2. Comparisons of expression levels across 8 mouse organs, 3 fetal stages and 2 cultured cell lines led to four observations: (i) The c-fos-2 transcript is ubiquitously synthesized either in vivo or in vitro situations. (ii) This isoform is present in amounts that are higher or similar to those of mRNAs coding for other Fos family members like FosB, DeltaFosB, Fra-1 or Fra-2. (iii) The c-fos-2 variant is frequently processed in certain mouse tissues, like ovary and lung, and in confluent cell cultures, where both transcript isoforms are produced in about equal quantities. (iv) No obvious relationship exists between total amount of c-fos transcripts and the relative quantity of the c-fos-2 form. For instance, c-fos-2 accounted for about 9% of total transcript molecules in liver and about 6% in brain, though this last organ exceeds the hepatic steady-state amount by over 75-fold. On the whole, these findings support the notion that the c-fos-2 copy number might be controlled.
###end p 48
###begin p 49
###xml 190 193 190 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
The number of copies of any transcript is determined by a delicate balance between opposing synthesis and degradation mechanisms. Here we show that the presence of intron 3 confers to the c-fos-2 transcript a destabilizing effect of about 6-fold, e.g. reducing the transcript half-life from 18 to 3 min in confluent NIH 3T3 cells (Fig. 4).
###end p 49
###begin p 50
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 484 488 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 494 497 494 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 655 656 655 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 728 731 728 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 876 879 876 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 1264 1266 1264 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1273 1275 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1417 1420 1417 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1481 1485 1481 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
The canonical c-fos mRNA is targeted for decay by two functionally independent instability determinants. One of these determinants (designated mCRD) is located in the protein-coding region and the other (an AU-rich element) in the 3'-untranslated end of the c-fos mRNA [22]. The mRNA decay mediated by mCRD represents a "suicide" mechanism in which translation of the mCRD-containing RNA results in the rapid degradation of the message [23]. Here we show that the half-lives of the c-fos and c-fos-2 transcripts are affected differently by inhibition of the translation, since cycloheximide caused the stabilization of only the canonical c-fos mRNA (Fig. 5). This result suggests that the shorter half-life of the alternative c-fos-2 species is independent of translationally coupled mRNA turnover mechanisms, like the one directed by the mCRD determinant. Accordingly, the c-fos-2 transcript with the PTC lying in the last intron 3 (Fig. 8A) should be also immune to the so-called nonsense-mediated decay (NMD). It is noteworthy that this latter was anticipated given that one critical determinant of whether a mammalian transcript is subjected to NMD is the presence of a splicing-generated exon-exon junction >50-55 nt downstream the PTC (recently reviewed in [24] and [25]). In the absence of these two translationally coupled mRNA turnover mechanisms, an intriguing question remains to be answered: Why is the c-fos-2 transcript degraded at a faster rate than the canonical c-fos message?.
###end p 50
###begin p 51
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 133 142 133 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 398 401 398 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 536 540 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 617 619 617 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink">20</sub>
###xml 762 764 762 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 841 842 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 860 862 860 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 916 920 916 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 926 929 926 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1047 1049 1047 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1122 1123 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 1311 1315 1311 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1324 1332 1324 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1336 1345 1336 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1346 1348 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1349 1351 1349 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1445 1448 1445 1448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
A recent paper by Moraes et al [26] indicates that the CUG-binding protein (CUG-BP) plays a role in c-fos mRNA decay. By means of an in vitro deadenylation assay, they showed that CUG-BP binding to c-fos mRNA stimulates the poly(A) shortening by the PARN deadenylase. Since deadenylation is a rate-limiting step in the turnover of most mRNAs, we hypothesized that the presence of intron 3 in the c-fos-2 transcript might accelerate its decay by the above-referred mechanism. We reasoned that in this case, the proportion between both c-fos transcript variants might change when using an anchored oligo(dT)primer (5'-T20VN-3'), rather than random primers, in the cDNA synthesis. This approach allowed us to track specifically the transcripts that retained poly(A)+ tails of a sufficient length to allow priming. We found [see Additional file 4] that the poly(A)+ population has practically the same copy numbers of c-fos and c-fos-2 transcripts as the overall RNA population. Moreover, the rate at which each transcript disappeared from the poly(A)+ population was similar to their overall decay rates [see Additional file 4]. These data seem to favour the idea that the two transcripts undergo deadenylation at the same rate, which seems to be in agreement with the synchronous deadenylation pattern seen for c-fos RNA both in vivo and in vitro [26,27]. Further work should pursue the identification of new instability determinants within the c-fos-2 transcript variant.
###end p 51
###begin p 52
###xml 5 11 5 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 12 14 12 14 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 300 303 300 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 655 659 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 673 676 673 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 779 783 779 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1082 1086 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1179 1183 1179 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1271 1273 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
Shur et al [13] have recently reported rapid changes in c-fos-2 and c-fos transcript levels in response of the osteoblastic cells to a challenge with dexamethasone (a pharmacological glucocorticoid hormone). Control of c-fos splicing through the interaction of the glucocorticoid receptor with the c-fos-2 transcript was the mechanism proposed to explain the observed changes. Here we too show that the proportion between both c-fos transcript variants changes rapidly and transiently upon the stimulation by serum of NIH 3T3 fibroblasts in quiescence. Our data indicate that differential rates of synthesis determine the large up-regulation of spliced c-fos relative to c-fos-2 level at the early stage of the serum response. However, destabilization of the newly synthesized c-fos message, possibly as it is being translated, contributes to completing the response and restoring the ~50% yield (percentage of total transcript molecules) quantitated in confluent cultures. This temporal sequence of events further supports the idea that the alternative processing of the primary c-fos transcript might be of physiological relevance, given that a relatively short extension of c-fos expression is sufficient for fibroblasts to manifest properties of cell transformation [28].
###end p 52
###begin p 53
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 549 550 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 909 910 905 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 911 913 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1091 1093 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1094 1096 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
Translation of the c-fos-2 transcript predicts the synthesis of a truncated protein lacking 211 aa at the carboxyl-terminus. We partially purified by immunoaffinity chromatography a c-Fos protein (verified by Western blot) with an apparent molecular weight of 23-kDa as judged by SDS-polyacrylamide gel electrophoresis. This finding suggests that the truncated variant of c-Fos is expressed in NIH 3T3 cells. The truncation would occur after the conserved basic domain for DNA binding but prior to the adjacent leucine zipper for dimerization (Fig. 8). Therefore, the truncated c-Fos should be inactive for transformation and transactivation since the functional integrity of the bZIP motif is required for these activities [29]. Moreover, the truncated c-Fos (unable to heterodimerize) should not exhibit antagonistic functional properties with the canonical longer counterpart, as in the case of DeltafosB [9-11]. On the other hand, however, the truncated c-Fos species might gain in stability as predicted by the loss of the main destabilizing activity residing at the C-terminal region [30,31].
###end p 53
###begin p 54
###xml 194 197 194 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1077 1079 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1301 1303 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1361 1363 1361 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
What might the biological significance of the above-referred truncated variant of c-Fos protein be? One could speculate with the idea that the truncated species is just the side effect of the c-fos-2 translation occurring or tolerated in the cells. Nonetheless, a more active role in regulating gene expression could also be envisaged, since the truncated c-Fos would retain the DNA binding domain (Fig. 8). Two pathways have been described for binding dimeric proteins to DNA. In the dimer pathway, proteins first form dimers and then go on to bind DNA. Along the monomer pathway, a monomer*DNA complex is formed first, followed by recruitment of the second monomer to form the final complex. A growing number of dimeric DNA-binding proteins are able to form complexes with DNA via a monomer pathway. In fact, the monomer pathway is considered the best option for a faster and more specific formation of the final complex ([32] and references herein). Although Fos and Jun monomer*DNA complexes are difficult to observe, particularly in gel retardation experiments (e.g. see [33]), recent stopped-flow fluorescence studies on the kinetics of Fos*Jun*DNA complex formation indicate that both protein monomers bind DNA sequentially and assemble their dimerization interface while interacting with DNA [32]. These data allow us to speculate with the possibility [34] that even low levels of the truncated c-Fos variant might influence AP-1 mediated gene expression through the formation of non-productive monomer*DNA intermediates at specific DNA target sites. Additional experiments would be required to support such a notion.
###end p 54
###begin title 55
Conclusion
###end title 55
###begin p 56
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 233 236 233 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 294 297 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 337 345 337 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 390 399 390 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 615 619 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 634 637 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 771 775 771 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 855 858 855 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 354 359 <span type="species:ncbi:10090">mouse</span>
###xml 410 416 <span type="species:ncbi:10090">murine</span>
Here we provide the first absolute (molecule number) quantitative analysis of alternative spliced transcript isoforms derived from the c-fos precursor RNA. We confirm that intron 3 remains in the transcript population derived from c-fos. We demonstrate that this transcript (here referred as c-fos-2) is ubiquitously synthesized, either in vivo (various mouse-tissues, gestational-ages) or in vitro (different murine cell lines), in amounts that are higher or similar to those of mRNAs coding for other Fos family members. Changes in the synthesis and/or degradation rates of both isoforms (the canonical spliced c-fos mRNA and the c-fos-2 variant) indicate a co-ordinated fine-tune of transcript molecules, supporting the notion that the alternative processing of the c-fos precursor RNA might be physiologically relevant. Moreover, translation of the c-fos-2 transcript predicts the synthesis of a truncated c-Fos protein. We detected a c-Fos immunoreactive species corresponding in mobility to the predicted truncated protein.
###end p 56
###begin title 57
Methods
###end title 57
###begin title 58
Cell culture and treatments
###end title 58
###begin p 59
###xml 250 252 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 280 282 280 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 139 143 <span type="species:ncbi:9913">calf</span>
###xml 165 171 <span type="species:ncbi:9913">bovine</span>
NIH 3T3 (ATCC: CRL-1658) and Hepa1-6 (ATCC: CRL-1830) cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% calf serum (CS) or foetal bovine serum, respectively. For mRNA decay quantitation, cells were seeded into 75 cm2 flask at a density of 3 x 106 cells/flask and cultivated for 48 h before the addition of 10 mug/ml actinomycin D (AmD). At different times thereafter, cells were scraped, washed once with phosphate-buffered saline, and immediately frozen in liquid nitrogen for total RNA purification. For serum stimulation, NIH 3T3 cells were made quiescent by 48 h incubation in DMEM with 0.5% CS. Cultures were then stimulated by re-feeding quiescent cells with 15% CS. Cells were incubated further and collected at different times as for AmD treatment. Data presented are means of at least two independent cell cultures.
###end p 59
###begin title 60
Primer design
###end title 60
###begin p 61
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 284 287 284 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 363 368 363 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 648 650 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
Primers directed against different regions of the c-fos and fosB genes (Fig. 1A) were designed with the Oligo 6.1 software (Molecular Biology Insights), as detailed in [35]. Primer positions (Fig. 1B) were chosen to detect intron sequences in the transcript population derived from c-fos. For comparison, primers for quantitation of the two well-defined forms of fosB transcript were also designed [9-11]. To obtain high specificity and performance, primers were required to have high Tm (>/=82degreesC), optimal 3'-DeltaG (>/= - 3 kcal/mol) value, and to be hairpin and duplex free. All primer pairs produced amplicons of the predicted size (Fig. 1C). All PCR products were further verified by nucleotide sequencing (ABI 377 DNA sequencer).
###end p 61
###begin title 62
RNA preparations and reverse transcription
###end title 62
###begin p 63
###xml 400 409 391 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
Total RNA was extracted by using Tri-Reagenttrade mark (Sigma) according to the manufacturer's protocol. Contaminating genomic DNA was removed by DNase I (Ambion). RNA quality was checked electrophoretically and quantitation was made spectrophotometrically. Lack of DNA contamination was confirmed by PCR amplification of RNA samples without previous cDNA synthesis. The standard RNA was synthesized in vitro from a laboratory-engineered DNA fragment containing a T7 polymerase-binding site, by means of a commercial RNA transcription kit (Stratagene). cDNA was generated from 2 mug of total RNA from each sample, using the M-MLV reverse transcriptase (Life Technologies) and random hexamers (Invitrogen).
###end p 63
###begin title 64
Real-time PCR
###end title 64
###begin p 65
###xml 118 119 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 122 123 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 131 132 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 654 655 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 734 738 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 742 747 721 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fosB </italic>
###xml 827 829 806 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 903 904 882 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
###xml 997 999 976 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1004 1006 983 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9 </sup>
###xml 1041 1042 1020 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 1170 1172 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1209 1210 1188 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 1228 1232 1207 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 1623 1624 1598 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
Real-time PCR reactions were performed in quadruplicate by using 50 ng of cDNA template, 0.3 muM of each primer (Fig. 1), 3 mM MgCl2, 250 muM of each dNTP, 0.75 units of Platinum Taq DNA polymerase, and 1:100000 SYBR Green I dye (Roche) in a volume of 25 mul. Reactions were analyzed on an iCycler iQ Real-Time PCR System (BioRad). Cycling conditions were as follows: 2 min at 95degreesC for the Platinum Taq activation and 40 cycles for the melting (15 s, 95degreesC) and annealing/extension (30 s, 70degreesC) steps. Replicate PCR reactions generated highly reproducible results with SEM <10% of the mean (<1% for threshold cycle) [see Additional file 5]. No primer-dimers were detected. Primers used for absolute quantitation of c-fos and fosB transcripts showed optimal (~100%) PCR efficiencies in the range of 20 to 2 x 105 pg of total RNA input with high linearity (r > 0.99) [see Additional file 6]. An absolute calibration curve was constructed with an external standard in the range of 102 to 109 RNA molecules [see Additional file 5]. The number of transcript molecules was calculated from the linear regression of the standard curve, as described previously [16] and exemplified in Additional file 5. The amount of c-fos mRNA molecules lacking intron 3 was estimated by subtracting the molecules with intron 3 (determined with E3U-I3L) from the total molecule number (determined with E3U-E4L). Similarly, the amount of mRNA molecules coding for DeltaFosB was estimated by subtracting the molecules for the full-length FosB (determined with I4U-I4L) from the total molecule number (determined with E4U-E5L) (Fig. 1).
###end p 65
###begin title 66
Immunoaffinity purification of c-Fos proteins
###end title 66
###begin p 67
###xml 514 515 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 517 518 516 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 861 863 858 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 0 6 <span type="species:ncbi:9986">Rabbit</span>
Rabbit polyclonal Ab (Calbiochem, PC05) against the N-terminal region (aa 4-17) shared by the full-length and the putative truncated c-Fos protein were coupled to cyanogen bromide (CNBr)-activated agarose (Sigma C9142) following the manufacturer's recommendations. NIH 3T3 cells were cultured as described above. The accumulation of c-Fos proteins was promoted by 30 min serum stimulation. The cells were harvested and then lysed in 150 mul of buffer A (50 mM Tris-HCl pH7.4, 150 mM NaCl, 0.03% Tween 20, 0.4 mM Na3VO4, 0.4 mM EDTA, 10 mM NaF, 10 mM sodium pyrophosphate, 10 mug/ml aprotinin, 10 mug/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride), by using a polypropylene pestle for microcentrifuge tubes mounted in a cordless motor and 4 cycles of freezing in liquid nitrogen and thawing at room temperature. The cell lysate was centrifuged at 16000 x g for 10 min at 4degreesC. The resulting supernatant (crude extract) was applied to the immunoaffinity column, which was then washed extensively with buffer A. The bound proteins were eluted with two volumes of 100 mM glycine-HCl (pH 2.8). The eluate from the immunoaffinity column was neutralized with NaOH for Western blot analysis as described below.
###end p 67
###begin title 68
Western blotting
###end title 68
###begin p 69
###xml 532 538 <span type="species:ncbi:9986">rabbit</span>
###xml 570 581 <span type="species:ncbi:3704">horseradish</span>
Proteins were separated on 12% sodium dodecyl sulfate (SDS)-polyacrylamide gel and transferred onto Hybond-P PVDF membrane (Amersham Biosciences) by electroblotting. Membranes were blocked with 2% non-fat milk powder in TTBS (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 0.03% Tween-20) for 4-5 h at room temperature and then incubated overnight with 1:250 of primary Ab (Anti-c-Fos, Calbiochem PC05) in blocking buffer at 4degreesC. After washing the blots with blocking buffer, the membranes were incubated with 1:4000 of a secondary anti-rabbit IgG Ab (Sigma, A9169) to which horseradish peroxidase had been covalently coupled. Blots were developed using the ECL-Plus kit (Amersham Biosciences) following the manufacturer's instructions. The membranes were stripped by washing 30 min in stripping buffer (0.2 M glycine pH2.5, 0.1% SDS) at room temperature and reprobed with 1:2000 of anti-GAPDH Ab (Santa Cruz Biotechnology, sc-25778) for control loading.
###end p 69
###begin title 70
Abbreviations
###end title 70
###begin p 71
###xml 158 162 <span type="species:ncbi:9913">calf</span>
AP-1, activator protein-1; bZIP, basic leucine-zipper; RT, reverse transcription; PCR, polymerase chain reaction; DMEM, Dulbecco's modified Eagle medium; CS, calf serum; AmD, actinomycin D; Cx, cycloheximide; aa, amino acid(s); Ab, antibody(ies); nt, nucleotide(s); DNase, deoxyribonuclease; PTC, premature termination codon; kDa, kilodalton(s)
###end p 71
###begin title 72
Competing interests
###end title 72
###begin p 73
The author(s) declares that there are no competing interests.
###end p 73
###begin title 74
Authors' contributions
###end title 74
###begin p 75
JJ carried out the purification of c-Fos proteins and CAF-A the absolute quantification of transcripts. In addition, both participated in the rest of the experiments and JJ helped to draft the manuscript. MJP-A participated in the determination of transcript half-lives and provided some cell culture samples. CP supervised the study design, participated in data analysis and drafted the manuscript. All the authors read and approved the final manuscript.
###end p 75
###begin title 76
Supplementary Material
###end title 76
###begin title 77
Additional file 1
###end title 77
###begin p 78
###xml 127 130 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 217 221 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 251 254 251 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
Empirical and theoretical decay of c-fos transcript. Various theoretical decays were generated under the assumption that the c-fos-2 transcript is merely a splicing intermediate and therefore the molecule number of c-fos might increase on behalf of c-fos-2 in a time-dependent manner in the presence of the transcription inhibitor AmD. Theoretical data are compared with experiment results shown in Fig. 4.
###end p 78
###begin p 79
Click here for file
###end p 79
###begin title 80
Additional file 2
###end title 80
###begin p 81
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
Confirmation that the ~23-kDa band detected by Western blot is not the primary Ab light chain. The E-30 eluate was subjected to inmunoblot analysis as described in Fig. 8. The ~23-kDa band was not detected when using only the secondary Ab, excluding the possibility that this band might be anti-cFos Ab light chains leaching off the immunoaffinity column.
###end p 81
###begin p 82
Click here for file
###end p 82
###begin title 83
Additional file 3
###end title 83
###begin p 84
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 772 775 772 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 880 881 880 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 111 117 <span type="species:ncbi:9986">rabbit</span>
###xml 290 296 <span type="species:ncbi:9986">rabbit</span>
###xml 542 547 <span type="species:ncbi:10090">mouse</span>
###xml 607 612 <span type="species:ncbi:10090">mouse</span>
###xml 670 675 <span type="species:ncbi:10090">mouse</span>
Confirmation that the ~23-kDa band detected by Western blot is not a non-specific protein co-purified with the rabbit anti-cFos Ab. c-Fos proteins were partially purified by immunoaffinity chromatography as described under "Methods" for the experiment in Fig. 8. The exception was that the rabbit polyclonal anti-cFos Ab (Calbiochem, PC05) was coupled to N-hydroxysuccinimide (NHS)-activated (instead of to CNBr-activated) Sepharose (Amersham Biosciences 28-903-28). Western blotting was as described under "Methods", except for the primary (mouse monoclonal anti-cFos; Calbiochem OP17) and secondary (anti-mouse IgG; Sigma A9917) Ab. The immunogen used to generate the mouse anti-cFos Ab was a synthetic peptide corresponding to aa residues 128-152 (translation of the c-fos-2 transcript predicts the synthesis of a truncated protein 169 aa long). For other details see the Fig. 8 legend.
###end p 84
###begin p 85
Click here for file
###end p 85
###begin title 86
Additional file 4
###end title 86
###begin p 87
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 323 325 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 467 471 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos </italic>
###xml 477 480 477 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
Comparison between poly(A)+ and overall RNA populations. Total RNAs from NIH 3T3 cells treated as in Fig. 4 were retrotranscribed with random hexamers (see "RNA preparations and reverse transcription" subsection of "Methods") or anchored oligo(dT)primer (5'-T20VN-3') (Invitrogen). A) Overall (solid symbols) versus poly(A)+ (open symbols) decay rate of c-fos-2 (circles) and c-fos (triangles) transcripts, respectively. B) Starting amounts (100% at time 0 min) of c-fos and c-fos-2 transcripts.
###end p 87
###begin p 88
Click here for file
###end p 88
###begin title 89
Additional file 5
###end title 89
###begin p 90
###xml 169 178 169 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 312 318 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gapdh </italic>
###xml 592 594 592 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9 </sup>
###xml 599 601 599 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1092 1102 1092 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">[-1/slope]</sup>
###xml 1319 1322 1319 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1403 1406 1403 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fos</italic>
###xml 1475 1476 1475 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
###xml 1343 1348 <span type="species:ncbi:10090">mouse</span>
###xml 1444 1449 <span type="species:ncbi:10090">mouse</span>
Absolute standard curve used to calculate the number of copies of each experimental transcript per pg of total RNA. A) The absolute standard curve was prepared with the in vitro synthesized standard RNA. The standard RNA [16] was a 457-nt fragment identical in sequence (except for a 7-bp deletion) to the mouse gapdh transcript (from 316 to 779 position in GenBank sequence ). The concentration of the standard RNA was determined by measuring the optical density at 260 nm and converting the absorbance to the number of copies by using its molecular weight. Ten-fold serial dilutions from 109 to 102 RNA copies were prepared, retrotranscribed and amplified by real-time PCR. Primers for the amplification of the standard have been previously described [16]. These primers generate a 130 bp PCR product. The standard curve was constructed by plotting the log of starting RNA molecules versus the threshold cycle (Ct). The resulting standard curve is linear (r = 0.998) over 7 orders of magnitude. The efficiency (E) value is calculated from the slope of the standard curve equation, as E = 10[-1/slope]-1. The slope of the standard curve indicates that the standard is amplified with 99.8% efficiency. This standard curve was used to determine the number of copies of each experimental transcript, as exemplified for c-fos-2 in total RNA from mouse ovary. B) Ct values used in the quantitation of the c-fos-2 transcript in 4 out of the 8 adult mouse tissues analyzed in Fig. 2. Real-time PCR reactions were carried out in quadruplicate by using 50 ng of cDNA template.
###end p 90
###begin p 91
Click here for file
###end p 91
###begin title 92
Additional file 6
###end title 92
###begin p 93
###xml 104 106 104 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 115 117 115 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1 </sup>
Real-time PCR efficiency of experimental transcript amplification. Ten-fold serial dilutions from 2 x 105 to 2 x 101 pg of total RNA input were prepared, retrotranscribed and amplified by real-time PCR. RNA sample was a pool of available total RNA from culture cells. A plot of the log RNA dilution versus the Ct value was made for each pair of primers, as exemplified here for E3U-E4L and E3U-I3L primers. Investigated transcripts showed optimal real-time PCR efficiencies of ~100% with a very high linearity (r>0.99) over 4 orders of magnitude.
###end p 93
###begin p 94
Click here for file
###end p 94
###begin title 95
Additional file 7
###end title 95
###begin p 96
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 202 207 <span type="species:ncbi:10090">mouse</span>
PCR products amplified with E1U-E2L primer pair. Agarose (1.5%) gel electrophoresis analysis of PCR products generated by E1U-E2L primer pair. Cycling conditions were as in Fig. 1. Genomic DNA was from mouse liver. For comparison, total RNA from NIH 3T3 cells and cDNA retrotranscribed from this RNA were amplified in parallel with genomic DNA.
###end p 96
###begin p 97
Click here for file
###end p 97
###begin title 98
Acknowledgements
###end title 98
###begin p 99
The work was supported by the Spanish Ministerio de Educacion y Ciencia (Grant BFU2005-02896) and co-financed by FEDER funds. JJ and MJP-A were funded by the Spanish Ministerio de Ciencia y Tecnologia (Ramon y Cajal Programme). CAF-A was recipient of a predoctoral fellowship from the Spanish Ministerio de Educacion y Ciencia (Formacion de Personal Investigador Programme).
###end p 99
###begin article-title 100
AP-1 subunits: quarrel and harmony among siblings
###end article-title 100
###begin article-title 101
The Fos family of transcription factors and their role in tumourigenesis
###end article-title 101
###begin article-title 102
Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells
###end article-title 102
###begin article-title 103
Viral and cellular fos proteins: a comparative analysis
###end article-title 103
###begin article-title 104
Posttranscriptional regulation of c-fos mRNA expression
###end article-title 104
###begin article-title 105
c-Fos transrepression revisited
###end article-title 105
###begin article-title 106
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Alternative splicing of mouse transcription factors affects their DNA-binding domain architecture and is tissue specific
###end article-title 106
###begin article-title 107
###xml 72 82 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
FOS-1 promotes basement-membrane removal during anchor-cell invasion in C. elegans
###end article-title 107
###begin article-title 108
A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity
###end article-title 108
###begin article-title 109
An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins
###end article-title 109
###begin article-title 110
Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins
###end article-title 110
###begin article-title 111
Induction of unspliced c-fos messenger RNA in rodent brain by kainic acid and lipopolysaccharide
###end article-title 111
###begin article-title 112
Dexamethasone regulation of cFos mRNA in osteoprogenitors
###end article-title 112
###begin article-title 113
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Absolute mRNA levels and transcriptional regulation of the mouse testis-specific thioredoxins
###end article-title 113
###begin article-title 114
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse
###end article-title 114
###begin article-title 115
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Absolute quantitation of normal and ROS-induced patterns of gene expression: an in vivo real-time PCR study in mice
###end article-title 115
###begin article-title 116
###xml 66 77 <span type="species:ncbi:10096">Mus spretus</span>
Absolute transcript expression signatures of Cyp and Gst genes in Mus spretus to detect environmental contamination
###end article-title 116
###begin article-title 117
###xml 86 110 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Absolute transcript levels of thioredoxin- and glutathione-dependent redox systems in Saccharomyces cerevisiae: response to stress and modulation with growth
###end article-title 117
###begin article-title 118
Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription
###end article-title 118
###begin article-title 119
c-Fos phosphorylation induced by H2O2 prevents proteasomal degradation of c-Fos in cardiomyocytes
###end article-title 119
###begin article-title 120
DeltaFosB: a molecular switch for long-term adaptation in the brain
###end article-title 120
###begin article-title 121
The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways
###end article-title 121
###begin article-title 122
A mechanism for translationally coupled mRNA turnover: Interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex
###end article-title 122
###begin article-title 123
A new function for nonsense-mediated mRNA-decay factors
###end article-title 123
###begin article-title 124
Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells
###end article-title 124
###begin article-title 125
CUG-BP binds to RNA substrates and recruits PARN deadenylase
###end article-title 125
###begin article-title 126
Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay
###end article-title 126
###begin article-title 127
Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle
###end article-title 127
###begin article-title 128
The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation
###end article-title 128
###begin article-title 129
The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression
###end article-title 129
###begin article-title 130
Molecular interpretation of ERK signal duration by immediate early gene products
###end article-title 130
###begin article-title 131
Kinetic studies of Fos*Jun*DNA complex formation: DNA binding prior to dimerization
###end article-title 131
###begin article-title 132
###xml 32 38 <span type="species:ncbi:10090">murine</span>
DNA binding activities of three murine Jun proteins: stimulation by Fos
###end article-title 132
###begin article-title 133
Highly specific DNA recognition by a designed miniature protein
###end article-title 133
###begin article-title 134
Multiplex reverse transcription-polymerase chain reaction for determining transcriptional regulation of thioredoxin and glutaredoxin pathways
###end article-title 134
###begin article-title 135
###xml 76 81 <span type="species:ncbi:4932">yeast</span>
Transcript copy number of genes for DNA repair and translesion synthesis in yeast: contribution of transcription rate and mRNA stability to the steady-state level of each mRNA along with growth in glucose-fermentative medium
###end article-title 135

